Product Information

CAPTOPRIL 50 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.4547 per EA under NDC 27241016201. Its NADAC has been published 319 times since Oct 14, 2020.

FDA first approved this application on Dec 13, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CAPTOPRIL 50 MG TABLET

Captopril
$0.4547per EA

Strength

50 mg/1

NDC

27241016201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CAPTOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA212809

FDA Approved

12/13/2019

TE Code

AB

On Market Since

12/13/2019

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for CAPTOPRIL 50 MG TABLET has been published 319 times since Oct 14, 2020, and over the history we have for it it has declined 55.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4547 per EA
All-time high$1.2596 (Apr 13, 2022)
All-time low$0.2326 (Oct 18, 2023)
52-week high$0.4547
52-week low$0.2335
Median price$0.3736
Average price$0.5135
Largest weekly change+134.2% (Aug 23, 2023)
Weeks tracked319
Tracking sinceOct 14, 2020

Price History

1W

+2.1%

1M

+23.2%

3M

+46.8%

6M

+85.3%

1Y

+42.4%

3Y

+95.5%

5Y

-36.0%

All

-55.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 28% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CAPTOPRIL 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CAPTOPRIL 50 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.4547 per EA (NDC 27241016201), effective Nov 18, 2026.

How has the price of CAPTOPRIL 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for CAPTOPRIL 50 MG TABLET has declined 55.7%. It has been tracked across 319 weekly CMS publications since Oct 14, 2020.

What are the highest and lowest recorded NADAC prices for CAPTOPRIL 50 MG TABLET?

Since Oct 14, 2020, the NADAC for CAPTOPRIL 50 MG TABLET has ranged from a low of $0.2326 (Oct 18, 2023) to a high of $1.2596 (Apr 13, 2022), with a median of $0.3736 per EA.

Are there cheaper alternatives to CAPTOPRIL 50 MG TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CAPTOPRIL 50 MG TABLET, is $0.3254 per EA — about 28% below CAPTOPRIL 50 MG TABLET.

Who manufactures CAPTOPRIL 50 MG TABLET?

CAPTOPRIL 50 MG TABLET (NDC 27241016201) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.